Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy.

Xue G, Li X, Kalim M, Fang J, Jiang Z, Zheng N, Wang Z, Li X, Abdelrahim M, He Z, Nikiforov M, Jin G, Lu Y
Cancer Cell. 2024 May 13;42(5):780-796.e6. doi: 10.1016/j.ccell.2024.03.001. Epub 2024 Mar 21. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.